Adam Keeney
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
Adam Keeney is Executive VP & Head-Corporate Development at Biogen, Inc. since 2023.
Formerly, Dr. Keeney was President, Chief Executive Officer & Director at NodThera Ltd. from 2018 to 2022.
Dr. Keeney completed undergraduate studies at the University of Leeds and earned a doctorate from The University of Nottingham.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-05-2026 | 6.365 ( 0% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 17-04-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Algemeen Directeur | 01-01-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau